Ivor Ruste - Stantec Independent Director
| STN Stock | CAD 108.50 0.65 0.60% |
Director
Mr. Ivor M. Ruste is an Independent Director of Stantec Inc., since February 21, 2007. Mr. Ruste is currently executive vice president and CFO of Cenovus Energy Inc., a Canadian oil company headquartered in Calgary. He has a bachelor of commerce from the University of Alberta and is a fellow chartered accountant. From May 2006 to November 2009, Mr. Ruste worked at EnCana Corporationrationration, and before joining Cenovus, he was executive vice president, Corporationrationrate Responsibility and chief risk officer at EnCana. From 1998 to 2006, he was the managing partner of the Edmonton office of KPMG LLP and the Alberta regional managing partner and vice chair of the KPMG Canada board of directors. Mr. Ruste was active in numerous other business, community, and professional endeavors. since 2007.
| Age | 59 |
| Tenure | 17 years |
| Address | 10220-103 Street, Edmonton, AB, Canada, T5J 0K4 |
| Phone | 780 917-7000 |
| Web | https://www.stantec.com |
Stantec Management Efficiency
The company has return on total asset (ROA) of 0.0591 % which means that it generated a profit of $0.0591 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1314 %, meaning that it generated $0.1314 on every $100 dollars invested by stockholders. Stantec's management efficiency ratios could be used to measure how well Stantec manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.10. Also, Return On Capital Employed is likely to grow to 0.20. At this time, Stantec's Fixed Asset Turnover is very stable compared to the past year. As of the 23rd of April 2024, Return On Assets is likely to grow to 0.06, while Other Current Assets are likely to drop about 16.2 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Dennis DesRosiers | Autocanada | 68 | |
| Michael Ross | Autocanada | 65 | |
| Keith Graham | Element Fleet Management | 56 | |
| Maryann Keller | Autocanada | 75 | |
| Richard Venn | Element Fleet Management | 65 | |
| Sylvie Tendler | Knight Therapeutics | N/A | |
| Edward Schutter | Knight Therapeutics | 63 | |
| Stephen Green | Autocanada | 67 | |
| Barry James | Autocanada | 61 | |
| Arlene Dickinson | Autocanada | 60 | |
| Jody Engel | Knight Therapeutics | N/A | |
| Sarit Assouline | Knight Therapeutics | N/A | |
| Joan LammTennant | Element Fleet Management | 66 | |
| Nancy Harrison | Knight Therapeutics | N/A | |
| Meir Jakobsohn | Knight Therapeutics | N/A | |
| Rocco Colella | Element Fleet Management | N/A | |
| Pierre Lortie | Element Fleet Management | 68 | |
| Brian Tobin | Element Fleet Management | 62 | |
| Gordon Giffin | Element Fleet Management | 65 | |
| Harold Bridge | Element Fleet Management | 71 | |
| Alexander Greene | Element Fleet Management | 60 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0591 |
Stantec Leadership Team
Elected by the shareholders, the Stantec's board of directors comprises two types of representatives: Stantec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stantec. The board's role is to monitor Stantec's management team and ensure that shareholders' interests are well served. Stantec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stantec's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Allen, COO and Executive VP | ||
| Janet Mulligan, Sr Treasury | ||
| Alan Krause, Executive Vice President | ||
| Gord Johnston, President CEO | ||
| Ivor Ruste, Independent Director | ||
| Theresa Jang, Chief Financial Officer, Executive Vice President | ||
| Catherine Schefer, Chief Operating Officer – Global | ||
| Steve Fleck, Executive Vice President, Chief Practice and Project Officer | ||
| Susan Hartman, Independent Director | ||
| Patricia Galloway, Independent Director | ||
| Stephen Phillips, Senior Buildings | ||
| Bjorn Morisbak, Executive Development | ||
| MarieLucie Morin, Independent Director | ||
| Tino DiManno, Senior Vice President | ||
| Emree Siaroff, Chief Human Resource Officer, Senior Vice President | ||
| Delores Etter, Independent Director | ||
| Paul Alpern, Senior Vice President General Counsel, Secretary | ||
| Douglas Ammerman, Independent Chairman of the Board | ||
| Asifa Samji, Executive Officer | ||
| Stuart Lerner, Chief Operating Officer – North America | ||
| Aram Keith, Independent Chairman of the Board | ||
| Marshall Davert, Chief Innovation Officer | ||
| David Emerson, Independent Director | ||
| Robert Gomes, President CEO, Director | ||
| Shelley Brown, Independent Director | ||
| Alison Tucker, Vice Development | ||
| John Take, Executive Officer | ||
| Richard Bradeen, Independent Director | ||
| Gordon PEng, CEO President | ||
| Daniel Lefaivre, CFO, Senior Vice President | ||
| Donald Lowry, Independent Director | ||
| Valentino Dimanno, Executive Vice President, Chief Business Officer | ||
| Anthony Franceschini, Independent Director | ||
| Gordon Johnston, President, Chief Executive Officer, Director | ||
| Scott Murray, Chief Operating Officer, Executive Vice President |
Stantec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Stantec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0591 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 13.76 B | ||||
| Shares Outstanding | 114.07 M | ||||
| Shares Owned By Insiders | 0.26 % | ||||
| Shares Owned By Institutions | 74.10 % | ||||
| Number Of Shares Shorted | 1.05 M | ||||
| Price To Earning | 21.49 X |
Currently Active Assets on Macroaxis
When determining whether Stantec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Stantec's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Stantec Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Stantec Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stantec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Stantec Stock, please use our How to Invest in Stantec guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Stantec Stock analysis
When running Stantec's price analysis, check to measure Stantec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stantec is operating at the current time. Most of Stantec's value examination focuses on studying past and present price action to predict the probability of Stantec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stantec's price. Additionally, you may evaluate how the addition of Stantec to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |